Atlas Trials

Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

Clinical trial NCT02860923 · COMPLETED

Trial details

NCT number
NCT02860923
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
CraniopharyngiomasHypothalamic Obesity
Start date
2017-01-11
Primary completion
2018-06-30
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.